Atlas Trials

Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery

Clinical trial NCT00410774 · TERMINATED

Trial details

NCT number
NCT00410774
Sponsor
University of California, San Francisco
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2006-07-01
Primary completion
2007-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.